Diego Cadavid's most recent trade in X4 Pharmaceuticals Inc was a trade of 97,000 Common Stock done . Disclosure was reported to the exchange on March 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals Inc | Diego Cadavid | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 97,000 | 104,107 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Diego Cadavid | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Feb 2022 | 928 | 7,107 (0%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Diego Cadavid | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 8,035 | 8,035 (0%) | 0% | 0 | Common Stock |